✦ LIBER ✦

A trial of individual dose intensity and relative performance factors in tegafur maintenance chemotherapy for head and neck cancer

✍ Scribed by S. Sawaki; H. Watanabe; T. Shine; T. Kubota; S. Komiyama; T. Umezaki; I. Nahm

Book ID: 112278521
Publisher: Springer-Verlag
Year: 1993
Tongue: English
Weight: 394 KB
Volume: 250
Category: Article
ISSN: 0302-9530
DOI: 10.1007/bf00180387

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors and effects of reduced relati

Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer

✍ R. Hanna; M. Poniwierski; R. Laskey; M. Lopez; A. Shafer; P. Gehrig; A. Alvarez- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 97 KB

The Effect of Significant Tumor Reductio

The Effect of Significant Tumor Reduction on the Dose Distribution in Intensity Modulated Radiation Therapy for Head-And-Neck Cancer: A Case Study

✍ James Mechalakos; Nancy Lee; Margie Hunt; C. Clifton Ling; Howard I. Amols 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 965 KB

Dose–response analysis of acute oral muc

Dose–response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer

✍ Shreerang A. Bhide; Sarah Gulliford; Ulrike Schick; Aisha Miah; Shane Zaidi; Kat 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Therapeutic effect of recombinant human

Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer : A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial

✍ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

3050 Three -day course of granulocyte co

3050 Three -day course of granulocyte colony-stimulating factor in patients on chemotherapy for cancer is a safe and cost-effective schedule to maintain dose-intensity: a study from India

✍ A. Chandra; J. Martin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB